Sana Biotechnology reclassifies director Steven D. Harr from Class I to Class III to balance board classes

Sana Biotechnology, Inc.

Director Steven D. Harr resigned as Class I director and was reappointed as Class III director effective April 22, 2026.
Change made solely to achieve equal board-class balance per certificate of incorporation.
Board now has three directors in each of Class I, II, and III.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.